§ Federal grant opportunity · HT942526BCRPCREA2
DoW Breast Cancer, Clinical Research Extension Award
Defense Health Agency Contracting Activity - DHACA is accepting applications for DoW Breast Cancer, Clinical Research Extension Award. The deadline is November 18, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Application deadline
- November 18, 2026
- Award range
- Award amount not published
- Eligibility
- unrestricted
- Geography
- United States
- Focus areas
- Science Technology And Other Research And Development
- Opportunity number
- HT942526BCRPCREA2
Program overview
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Defense Health Agency Contracting Activity - DHACA.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 18, 2026, allowing time for registration and validation.
Related grant opportunities
- DARRP Restoration Implementation Grants (2026)
- Improved quality of life of persons with disabilities in provinces heavily sprayed with agent orange in Ca Mau and Quang Ngai
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- FY27 Small Business Development Center State of Kansas Network Rebid
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.